BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 33042820)

  • 1. HPV Detection in Head and Neck Squamous Cell Carcinomas: What Is the Issue?
    Augustin JG; Lepine C; Morini A; Brunet A; Veyer D; Brochard C; Mirghani H; Péré H; Badoual C
    Front Oncol; 2020; 10():1751. PubMed ID: 33042820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
    Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method.
    D'Souza G; Westra WH; Wang SJ; van Zante A; Wentz A; Kluz N; Rettig E; Ryan WR; Ha PK; Kang H; Bishop J; Quon H; Kiess AP; Richmon JD; Eisele DW; Fakhry C
    JAMA Oncol; 2017 Feb; 3(2):169-177. PubMed ID: 27930766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    Economopoulou P; Koutsodontis G; Avgeris M; Strati A; Kroupis C; Pateras I; Kirodimos E; Giotakis E; Kotsantis I; Maragoudakis P; Gorgoulis V; Scorilas A; Lianidou E; Psyrri A
    PLoS One; 2019; 14(5):e0215984. PubMed ID: 31071126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk HPV detection by RNAscope in situ hybridization combined with Cdc2 protein expression by immunohistochemistry for prognosis of oropharyngeal squamous cell carcinoma.
    Yang JQ; Wu M; Han FY; Sun YM; Zhang L; Liu HX
    Int J Clin Exp Pathol; 2020; 13(8):2192-2200. PubMed ID: 32922620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.
    Randén-Brady R; Carpén T; Jouhi L; Syrjänen S; Haglund C; Tarkkanen J; Remes S; Mäkitie A; Mattila PS; Silén S; Hagström J
    Hum Pathol; 2019 Aug; 90():97-105. PubMed ID: 31121191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.
    Hauck F; Oliveira-Silva M; Dreyer JH; Perrusi VJ; Arcuri RA; Hassan R; Bonvicino CR; Barros MH; Niedobitek G
    Virchows Arch; 2015 Jun; 466(6):685-93. PubMed ID: 25820374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
    Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy-A Feasibility Study.
    Loermann G; Kolb M; Prascevic D; Siemert J; Wiegand S; Zebralla V; Pirlich M; Stöhr M; Dietz A; Wald T; Wichmann G
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical, radiological and morphological features including the distribution of HPV E6/E7 oncogenes in resection specimens of oropharyngeal squamous cell carcinoma.
    Channir HI; Kiss K; Rubek N; Andersen J; Georgsen JB; Rathje GS; Charabi BW; von Buchwald C; Lajer CB
    Oral Oncol; 2018 Mar; 78():163-170. PubMed ID: 29496046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the efficacy of the 4 tests (p16 immunochemistry, polymerase chain reaction, DNA, and RNA in situ hybridization) to evaluate a human papillomavirus infection in head and neck cancers: a cohort of 348 French squamous cell carcinomas.
    Augustin J; Outh-Gauer S; Mandavit M; Gasne C; Grard O; Denize T; Nervo M; Mirghani H; Laccourreye O; Bonfils P; Bruneval P; Veyer D; Péré H; Tartour E; Badoual C
    Hum Pathol; 2018 Aug; 78():63-71. PubMed ID: 29684499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proposal for classification of oropharyngeal squamous cell carcinoma: Morphology and status of HPV by immunohistochemistry and molecular biology.
    Rahimi S; Akaev I; Brennan PA; Virgo A; Marani C; Gomez RS; Yeoh CC
    J Oral Pathol Med; 2020 Feb; 49(2):110-116. PubMed ID: 31465605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus detection in head and neck squamous cell carcinomas.
    Snow AN; Laudadio J
    Adv Anat Pathol; 2010 Nov; 17(6):394-403. PubMed ID: 20966645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.